AU2002337062A1 - Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders - Google Patents

Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders

Info

Publication number
AU2002337062A1
AU2002337062A1 AU2002337062A AU2002337062A AU2002337062A1 AU 2002337062 A1 AU2002337062 A1 AU 2002337062A1 AU 2002337062 A AU2002337062 A AU 2002337062A AU 2002337062 A AU2002337062 A AU 2002337062A AU 2002337062 A1 AU2002337062 A1 AU 2002337062A1
Authority
AU
Australia
Prior art keywords
inflammatory
treatment
immunological disorders
ccr3 antagonists
arylsulfonamide derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002337062A
Inventor
Kevin Bacon
Keiko Fukushima
Norihiro Kawamura
Tetsuo Kikuchi
Yingfu Li
Timothy B. Lowinger
Toshiya Moriwaki
Toshiki Murata
Noriko Nunami
Takuya Shintani
Klaus Urbahns
Akihiko Watanabe
Megumi Yamauchi
Hiroko Yoshino
Takashi Yoshino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Publication of AU2002337062A1 publication Critical patent/AU2002337062A1/en
Abandoned legal-status Critical Current

Links

AU2002337062A 2001-09-07 2002-09-04 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders Abandoned AU2002337062A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001-272327 2001-09-07

Publications (1)

Publication Number Publication Date
AU2002337062A1 true AU2002337062A1 (en) 2003-03-24

Family

ID=

Similar Documents

Publication Publication Date Title
HK1109867A1 (en) Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
IL200580A0 (en) 2-phenoxy-and-2-phenylsulfonamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
AU2002322478A1 (en) Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders
PL374118A1 (en) Interleukin-1 receptors in the treatment of diseases
AU2003289888A1 (en) Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders
AU2003216585A8 (en) Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases
AU2003213787A1 (en) Compositions and methods for the treatment of anorectal disorders
AU2003228819A1 (en) Combinations for the treatment of inflammatory skin disorders
AU2003255993A1 (en) Diazabicyclic compounds useful in the treatment of cns and other disorders
AU2002337062A1 (en) Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
AU2002339673A1 (en) Agonists and antagonists of ryzn for the treatment of metabolic disorders
AU2002328173A1 (en) Omoxin agonists and antagonists for use in the treatment of metabolic disorders
AU2002339682A1 (en) Emergen agonists and antagonists for use in the treatment of metabolic disorders
AU2003215677A1 (en) N-(morpholin-2yl) methyl acetamide derivatives as ccr-3 antagonists useful in the treatment of inflammatory diseases
AU2002339680A1 (en) Agonists and antagonists of bromix for the treatment of metabolic disorders
AU2002321764A1 (en) Genobix agonists and antagonists for use in the treatment of metabolic disorders
AU2002324288A1 (en) Agonists and antagonists of genoxin for use in the treatment of metabolic disorders
AU2002339679A1 (en) Glucomin agonists and antagonists for use in the treatment of metabolic disorders
AU2002339674A1 (en) Ditacin agonists and antagonists for use in the treatment of metabolic disorders
AU2002313578A1 (en) Agonists and antagonists of cofoxin for use in the treatment of metabolic disorders
AU2002313581A1 (en) Lypergix agonists and antagonists for use in the treatment of metabolic disorders
AU2002313579A1 (en) Agonists and antagonists of famoset for use in the treatment of metabolic disorders
AU2002339689A1 (en) Dexar agonists and antagonists for use in the treatment of metabolic disorders
AU2002321774A1 (en) Agonists and antagonists of contabix for use in the treatment of metabolic disorders